JPLA
COCP icon

Joseph P. Lucia & Associates’s Cocrystal Pharma COCP Stock Holding History

Joseph P. Lucia & Associates’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17
Closed – – 159
2022
Q2 		$0 Hold
17
– – ﹤0.01% 452
2022
Q1 		$0 Buy
+17
New +$113 ﹤0.01% 450
2021
Q4 		– Sell
-92
Closed -$1K – 206
2021
Q3 		$1K Buy
92
+9
+11% +$119 ﹤0.01% 545
2021
Q2 		$1K Buy
83
+15
+22% +$228 ﹤0.01% 544
2021
Q1 		$1K Buy
68
+18
+36% +$366 ﹤0.01% 532
2020
Q4 		$1K Buy
+50
New +$695 ﹤0.01% 459

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Joseph P. Lucia & Associates's COCP Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of Cocrystal Pharma (COCP) in Q3 2022, closing a stake of 17 shares.

Joseph P. Lucia & Associates first reported a position in COCP in Q4 2020 and held it in 6 quarters. The position peaked at $1K in Q3 2021. 27 funds tracked by Wall St. Rank hold COCP as of Q3 2022.

  • Joseph P. Lucia & Associates reported no remaining Cocrystal Pharma position as of Q3 2022 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 17 Cocrystal Pharma shares in Q3 2022.
  • Joseph P. Lucia & Associates first reported a position in Cocrystal Pharma in Q4 2020 and held it in 6 quarters.
  • Joseph P. Lucia & Associates's Cocrystal Pharma position peaked at $1K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.